Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

DIEKO s.r.o.

Research site

Czechia Karlovarska 1632/30, Severni Predmesti, 301 00 Plzen, Czechia

  • Type 2 diabetes mellitus · Obesity
  • Adult patients

About Specializations

DIEKO s.r.o. in Plzen, Czechia specialises in clinical trials of conditions such as Type 2 diabetes mellitus, Obesity, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases and Nutritional and Metabolic Diseases

At DIEKO s.r.o. in Plzen, clinical research is focused on cardiovascular health and metabolic disorders, with studies centered on type 2 diabetes, metabolic syndrome, and obesity. These trials are designed to assess whether new treatments can improve weight management and support better control of related health risks.

  • Research on obesity and type 2 diabetes is evaluating a potential therapy for weight loss and metabolic improvement.
  • Studies in lipid management are examining approaches to lower LDL cholesterol in people with diabetes or metabolic syndrome.

The site is contributing to research that may help improve long-term treatment options for people living with these closely linked conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Karlovarska 1632/30, Severni Predmesti301 00 PlzenCzechia
Open in maps ↗
Recruiting now
no trials
Conditions studied
2

More sites in PlzenCzechia

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Type 2 diabetes mellitus

Not recruiting

A study to evaluate the effects of obicetrapib and ezetimibe on cholesterol levels in adults with type 2 diabetes or metabolic syndrome

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Ezetimibe
  • Sponsor:NewAmsterdam Pharma B.V.

Type 2 diabetes mellitus+1

Not recruiting

Study on the Effectiveness of Survodutide for Weight Loss in Patients with Type 2 Diabetes and Obesity

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim Espana S.A.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.